Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 6/20 | 0.50 |
| ▸ | HTR1B | P28222 | 4/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | HTR1A | P08908 | 2/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1022724 | 0.79 | ATM (0.38) | HTR1DHTR1BPOLBTSHRLMNA | |
| SCHEMBL954302 | 0.76 | HTT (0.32) | ATM | |
| SCHEMBL5728741 | 0.76 | CYP2A6 (0.33) | TSHRLMNAMAPTATMMEN1 | |
| SCHEMBL11860918 | 0.76 | CYP3A4 (0.41) | CHRM1ADRA1AHTR2BCYP3A4ATM | |
| SCHEMBL9248479 | 0.76 | GABRA1 (0.41) | HTR1DHTR1BPOLBMAPTGABRA1 | |
| SCHEMBL7982969 | 0.76 | CSNK2A1 (0.37) | HTR1DHTR1BATM | |
| SCHEMBL3255126 | 0.75 | PGK1 (0.40) | HTR1D | |
| SCHEMBL4399868 | 0.74 | TACR1 (0.40) | HTR1DHTR1BPOLBTSHRGABRA1 | |
| SCHEMBL7969434 | 0.74 | HTR1D (0.43) | HTR1DHTR1BPOLBTSHRADRA2A | |
| SCHEMBL5728530 | 0.72 | ALDH1A1 (0.40) | POLBTSHRLMNAMAPK1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709392-A1 | COMBINATION THERAPY GLUCOCORTICOIDS AND GINSENOSIDE | Fytagoras B.V. (NL) | 2026-03-18 | — | — | EP | claimed |
| WO-2024232756-A1 | COMBINATION THERAPY GLUCOCORTICOIDS AND GINSENOSIDE | FYTAGORAS B.V. (NL) | 2024-11-14 | — | — | WO | claimed |
| CN-115109787-B | Glycosyltransferase gene and application thereof in preparation of pseudo-ginseng/ginsenoside | 广西科学院 | 2023-07-14 | — | — | CN | claimed |
| US-20220400670-A1 | PROTOPANAXATRIOL (PPT)-TYPE COMPOUNDS AS ACTIVE INGREDIENTS IN INSECTICIDE PRODUCTS | STOCKTON (ISRAEL) LTD. (IL) | 2022-12-22 | — | — | US | claimed |
| CN-115109787-A | Group of glycosyltransferase genes and application thereof in preparation of panax notoginseng/ginsenoside | 广西科学院 | 2022-09-27 | — | — | CN | claimed |
| CN-122075502-A | Compound preparation for treating vascular dementia and preparation method thereof | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4709392-A1 | COMBINATION THERAPY GLUCOCORTICOIDS AND GINSENOSIDE | Fytagoras B.V. (NL) | 2026-03-18 | — | — | EP | disclosed |
| CN-121466152-A | Application of ginseng oil body in preparation of medicines for preventing and/or treating colonitis | 长春中医药大学附属医院(吉林省中医院) | 2026-02-06 | — | — | CN | disclosed |
| EP-4043560-B1 | GROUP OF GLYCOSYLTRANSFERASES AND USE THEREOF | GSYNBIOT SHANGHAI CO LTD (CN) | 2025-08-13 | — | — | EP | disclosed |
| US-12370205-B2 | Composition for preventing or treating fine dust-induced respiratory disease comprising mixture (RGX-365) comprising ginsenosides RG2, RG4, RG6 and RH1, as active ingredient, and preparation method thereof | AREZ CO., LTD. (KR) | 2025-07-29 | — | — | US | disclosed |
| CN-120137932-A | BS-YjiC mutant for conversion generation of ginsenoside and application thereof | 西北大学 | 2025-06-13 | — | — | CN | disclosed |
| CN-120114392-A | Ginsenoside liposome and preparation method and application thereof | 山东铂源生物医药有限公司 | 2025-06-10 | — | — | CN | disclosed |
| EP-3985110-A1 | GROUP OF GLYCOSYLTRANSFERASES AND USE THEREOF | CAS Center for Excellence in Molecular Plant Sciences (CN) | 2022-04-20 | — | — | EP | disclosed |
| CN-109234347-B | Method for converting protopanaxatriol saponin to obtain C25-OH derivative | 长春中医药大学 | 2022-03-01 | — | — | CN | disclosed |
| CN-114025770-A | Pharmaceutical composition for preventing alopecia or promoting hair growth comprising ginsenoside Rg4 or mixture of ginsenoside Rg2, Rg4, Rg6 and RH1 (RGX 365) | AREZ株式会社 | 2022-02-08 | — | — | CN | disclosed |
| US-6288101-B1 | ADMINISTERING COMPOUNDS SUCH AS 2,6-DIMETHYL-4-ISOPROPYLBENZALDEHYDE TO TREAT INDICATIONS WHERE STIMULATION OF SUBTYPES OF THE SEROTONIN RECEPTOR IS IMPLICATED, SUCH AS MIGRAINES | VIRGINIA COMMONWEALTH UNIVERSITY | 2001-09-11 | — | — | US | disclosed |
| US-6124338-A | TREATING MIGRAINE HEADACHE | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2000-09-26 | — | — | US | disclosed |
| US-6048862-A | Benzylamidine derivatives with serotonin receptor binding activity | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2000-04-11 | — | — | US | disclosed |
| US-5969137-A | TREATMENT OF NERVOUS SYSTEM DISORDERS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1999-10-19 | — | — | US | disclosed |
| WO-1998012183-A1 | IMIDAZOLES WITH SEROTONIN RECEPTOR BINDING ACTIVITY | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 1998-03-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220400670-A1 | PROTOPANAXATRIOL (PPT)-TYPE COMPOUNDS AS ACTIVE INGREDIENTS IN INSECTICIDE PRODUCTS | PPT1, TPP2, PTMA | HTR1D 3508/4885HTR1B 3117/4885POLB 4306/4885 |
| US-12370205-B2 | Composition for preventing or treating fine dust-induced respiratory disease comprising mixture (RGX-365) comprising ginsenosides RG2, RG4, RG6 and RH1, as active ingredient, and preparation method thereof | RDX, IL4, IL33 | HTR1D 4208/4885HTR1B 4597/4885POLB 4424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.